Edit
Carmot Therapeutics
http://www.carmot.us/Last activity: 03.04.2024
Active - Reference to CARMOT THERAPEUTICS
Employees: 1-10
Total raised: $150M
Investors 2
| Date | Name | Website |
| - | Spur Capit... | spurcapita... |
| 13.06.2023 | TCG Crosso... | tcgcrossov... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 31.05.2023 | Series E | $150M | Janus Hend... |
Mentions in press and media 10
| Date | Title | Description |
| 03.04.2024 | From generative chemistry to computational astrophysics, startups employ new methods to fight cancer | Here are a few startups in the cancer space that made headlines recently The recent revelation of Princess Kate Middleton’s battle with cancer has sent ripples across the globe, reminding us that this disease knows no boundaries of status o... |
| 20.12.2023 | Fierce Biotech Fundraising Tracker '23: Carmot spinoff Kimia raises $55M; Lassen fuels for fibro-inflammatory mission | We've launched a new Fierce Biotech Fundraising Tracker for 2023 to track all the venture capital flowing into the industry. While biotech VC investments in 2022 failed to live up to 2021's banner year, the second half still saw a steady st... |
| 31.05.2023 | Carmot Therapeutics Raises $150M in Series E Equity Financing | Carrot Therapeutics, a Berkeley, CA-based clinical-stage biotechnology company, raised $150M in Series E funding. The round was led by Deep Track Capital with participation from 5AM Ventures, Franklin Templeton, Frazier Life Sciences, Janus... |
| 26.07.2022 | Carmot Therapeutics Raises $160M in Series D Funding | Carmot Therapeutics, Inc., a Berkeley, CA-based clinical-stage biotechnology company applying its proprietary drug discovery platform, Chemotype Evolution, to discover and develop disease-modifying therapies in metabolic disease and cancer,... |
| 17.03.2021 | Carmot Therapeutics Expands Leadership Team With Appointment of Manu Chakravarthy, MD, PhD as Chief Medical Officer and Executive Vice President of R&D | BERKELEY, Calif.--(BUSINESS WIRE)--Mar 17, 2021-- Carmot Therapeutics, Inc. (Berkeley, CA), a clinical stage biotechnology company advancing transformative therapies for patients with metabolic diseases, announced today the appointment of M... |
| 19.01.2018 | Term Sheet — Friday, January 19 | CRYPTO HYBRIDS Happy Friday, Term Sheet readers. Paid Content You can't secure what you can't see From ExtraHop HOT TAKES: Yesterday, I wrote about storage startup Omni and its decision to take the majority of its $25 million fundraise in R... |
| 18.01.2018 | Carmot Therapeutics Secures $15M in Financing | Carmot Therapeutics, Inc., a Berkeley, California-based biotech company dedicated to the discovery and development of innovative therapeutics generated through Chemotype Evolution, secured $15m in financing. The round was led by Horizons Ve... |
| 20.12.2010 | Carmot Therapeutics Receives Financing from Leader Ventures | Carmot Therapeutics Inc., a San Francisco, CA-based drug discovery company, has received an equipment financing from Leader Ventures. Carmot Therapeutics was founded by Drs. Stig K. Hansen and Daniel A. Erlanson in 2008 with the goal of com... |
| - | Carmot Therapeutics | “Drug Discovery and Development” |
| - | Novo Nordisk and Eli Lilly shares slide on new obesity drug trial from Roche | Novo Nordisk and Eli Lilly shares slid Wednesday on promising early-stage trial data from Roche’s latest obesity drug candidate. Roche said its experimental once-daily pill showed average weight loss of 6.1% in four weeks. The results come ... |